DK1497289T3 - Drug containing betamimetics and a new anticholinergic - Google Patents

Drug containing betamimetics and a new anticholinergic

Info

Publication number
DK1497289T3
DK1497289T3 DK03746158T DK03746158T DK1497289T3 DK 1497289 T3 DK1497289 T3 DK 1497289T3 DK 03746158 T DK03746158 T DK 03746158T DK 03746158 T DK03746158 T DK 03746158T DK 1497289 T3 DK1497289 T3 DK 1497289T3
Authority
DK
Denmark
Prior art keywords
drug containing
betamimetics
new anticholinergic
anticholinergic
containing betamimetics
Prior art date
Application number
DK03746158T
Other languages
Danish (da)
Inventor
Rolf Banholzer
Christopher John Montagu Meade
Helmut Meissner
Gerd Morschhaeuser
Michel Pairet
Michael P Pieper
Gerald Pohl
Richard Reichl
Georg Speck
Ingo Konetzki
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10256317A external-priority patent/DE10256317A1/en
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1497289T3 publication Critical patent/DK1497289T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention relates to novel medicament compositions based on long-acting beta2 agonists and salts of a novel anticholinesterase drug (I), to methods for the production of these compositions and their use in treating respiratory tract diseases.
DK03746158T 2002-04-12 2003-04-09 Drug containing betamimetics and a new anticholinergic DK1497289T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10216428 2002-04-12
DE10256317A DE10256317A1 (en) 2002-04-12 2002-12-03 Synergistic medicaments used for treating inflammaSynergistic medicaments used for treating inflammatory or obstructive respiratory tract diseases, cotory or obstructive respiratory tract diseases, contain quaternized scopine ester anticholinergic agntain quaternized scopine ester anticholinergic agent and beta-mimetic agent e.g. salmeterol salt ent and beta-mimetic agent e.g. salmeterol salt
PCT/EP2003/003669 WO2003087097A1 (en) 2002-04-12 2003-04-09 Medicaments containing betamimetic drugs and a novel anticholinesterase drug

Publications (1)

Publication Number Publication Date
DK1497289T3 true DK1497289T3 (en) 2005-10-24

Family

ID=29251756

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03746158T DK1497289T3 (en) 2002-04-12 2003-04-09 Drug containing betamimetics and a new anticholinergic

Country Status (19)

Country Link
EP (1) EP1497289B1 (en)
JP (1) JP2005529111A (en)
CN (1) CN1646527A (en)
AT (1) ATE302774T1 (en)
AU (1) AU2003232201B2 (en)
BR (1) BR0309185A (en)
CA (1) CA2481468C (en)
DK (1) DK1497289T3 (en)
ES (1) ES2248767T3 (en)
HR (1) HRP20040944B1 (en)
IL (1) IL164291A (en)
MX (1) MXPA04009916A (en)
NO (1) NO20044107L (en)
NZ (1) NZ536337A (en)
PL (1) PL213489B1 (en)
PT (1) PT1497289E (en)
RS (1) RS50735B (en)
UY (1) UY27757A1 (en)
WO (1) WO2003087097A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040950A1 (en) 2003-02-14 2005-01-01 Theravance Inc BIPHENYL DERIVATIVES AS AGONISTS OF ß2-ADRENERGIC RECEPTORS AND AS ANTAGONISTS OF MUSCARINAL RECEPTORS
US7244728B2 (en) 2004-03-17 2007-07-17 Boehringer Ingelheim International Gmbh Long acting betamimetics for the treatment of respiratory diseases
EP1577306A1 (en) * 2004-03-17 2005-09-21 Boehringer Ingelheim Pharma GmbH & Co.KG novel benzoxazinone derivatives as slow-acting betamimetics and use thereof in treatment of respiratory tract diseases
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
EP1850831B1 (en) 2005-02-25 2015-12-02 CHIESI FARMACEUTICI S.p.A. Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
US7994211B2 (en) 2005-08-08 2011-08-09 Argenta Discovery Limited Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
DE102005055963A1 (en) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
DE102005055957A1 (en) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
GB0602778D0 (en) 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (en) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Method for coating a surface of a component
JP5763053B2 (en) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Adapter, inhaler and atomizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5658268B2 (en) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
WO2011064164A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (en) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
JP6643231B2 (en) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
JP6580070B2 (en) 2014-05-07 2019-09-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Container, nebulizer, and use
PL3139984T3 (en) 2014-05-07 2021-11-08 Boehringer Ingelheim International Gmbh Nebulizer
LT3928818T (en) 2014-05-07 2023-03-27 Boehringer Ingelheim International Gmbh Nebulizer and container

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4108393A1 (en) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
DE10050994A1 (en) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease
DE10050995A1 (en) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New benzylic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease

Also Published As

Publication number Publication date
PL213489B1 (en) 2013-03-29
AU2003232201B2 (en) 2009-06-11
IL164291A0 (en) 2005-12-18
EP1497289B1 (en) 2005-08-24
CA2481468C (en) 2011-02-01
RS50735B (en) 2010-08-31
NO20044107L (en) 2004-11-04
EP1497289A1 (en) 2005-01-19
CN1646527A (en) 2005-07-27
MXPA04009916A (en) 2005-05-03
NZ536337A (en) 2007-05-31
AU2003232201A1 (en) 2003-10-27
CA2481468A1 (en) 2003-10-23
JP2005529111A (en) 2005-09-29
RS89804A (en) 2006-10-27
HRP20040944A2 (en) 2005-04-30
BR0309185A (en) 2005-02-15
WO2003087097A1 (en) 2003-10-23
ES2248767T3 (en) 2006-03-16
ATE302774T1 (en) 2005-09-15
PT1497289E (en) 2005-11-30
UY27757A1 (en) 2003-11-28
PL372450A1 (en) 2005-07-25
IL164291A (en) 2012-04-30
HRP20040944B1 (en) 2012-12-31

Similar Documents

Publication Publication Date Title
DK1497289T3 (en) Drug containing betamimetics and a new anticholinergic
YU35503A (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
IS8230A (en) Substitute 2-aminotetraline for use in the treatment of depression
DE60315492D1 (en) MEDICALLY USEFUL ARYLETHANOLAMINE COMPOUNDS
WO2004045618A3 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases
ATE365720T1 (en) AGONISTS OF BETA-ADRENORECEPTORS
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
EA200401365A1 (en) METHODS OF TREATMENT OF ILEUS
UA85707C2 (en) Benzoxazines for treating respiratory tract diseases
NO20073839L (en) Quinoline derivative, method of preparation and use thereof, and drug containing it
WO2003087049A3 (en) Pharmaceutical combinations containing heterocyclic compounds and a novel anticholinergic agent
RS20060293A (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
RS89904A (en) Medicaments containing steroids and a novel anticholinesterase drug
ATE252383T1 (en) USE OF 2-METHYL-THIAZOLIDINE-2,4-DICARBONIC ACID AND/OR ITS PHYSIOLOGICALLY TOLERABLE SALTS FOR THE PRODUCTION OF A MEDICATION FOR THE TREATMENT OF CANCER DISEASES
DE602004019096D1 (en) MEDICAMENTS FOR INHALATION WITH BETAMIMETICS AND ANTICHOLINERGICUM
BR0307703A (en) Drug compositions based on anticholinergic agents and egfr kinase inhibitors
UY26990A1 (en) NEW DRUG COMPOSITIONS
MXPA03008406A (en) Novel medicament compositions based on anticholinergic agents and endothelin antagonists.
ECSP045357A (en) MEDICINAL CONTAINING BETAMIMETICS AND A NEW ANTI-POLERIGEN
DE502007006951D1 (en) MEDICINAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
DK1581224T3 (en) Tiotropium-containing drug composition for inhalation
MXPA04002400A (en) Salicylic acid salts, methods for the production and use thereof as medicaments.